Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Liquidia Technologies Inc. (LQDA)

5.81   -0.1 (-1.69%) 09-19 23:24
Open: 5.97 Pre. Close: 5.91
High: 6.28 Low: 5.81
Volume: 1,252,089 Market Cap: 219M
Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. The company is headquartered in Durham, North Carolina and currently employs 63 full-time employees. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies. The firm is engaged in developing product candidates from its pipeline, LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. LIQ861 is an inhaled dry powder formulation of treprostinil designed to improve the therapeutic profile of treprostinil by enhancing deep-lung delivery and achieving higher dose levels than current inhaled therapies. LIQ865, has completed a Phase Ib clinical trial, is designed to deliver sustained-release particles of bupivacaine, a non-opioid anesthetic and to treat local post-operative pain.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.286 - 6.321 6.321 - 6.349
Low: 5.731 - 5.772 5.772 - 5.805
Close: 5.749 - 5.811 5.811 - 5.862

Technical analysis

as of: 2020-09-18 4:33:05 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 7.42     One year: 8.66
Support: Support1: 5.00    Support2: 4.16
Resistance: Resistance1: 6.35    Resistance2: 7.42
Pivot: 5.04
Moving Average: MA(5): 5.66     MA(20): 5.08
MA(100): 6.97     MA(250): 5.57
MACD: MACD(12,26): -0.04     Signal(9): -0.23
Stochastic oscillator: %K(14,3): 81.72     %D(3): 84.43
RSI: RSI(14): 57.11
52-week: High: 12.10  Low: 2.65  Change(%): 43.8
Average Vol(K): 3-Month: 39811  10-Days: 35624

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
LQDA has closed below upper band by 13.2%. Bollinger Bands are 31.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 17 Sep 2020
Is Liquidia Technologies Inc (LQDA) a Stock to Watch This Week? - InvestorsObserver

Thu, 17 Sep 2020
Liquidia Announces Special Meeting Date to Approve Proposed Acquisition of RareGen, LLC - GlobeNewswire

Mon, 14 Sep 2020
Liquidia Technologies, Inc.’s (NASDAQ:LQDA) Shift From Loss To Profit - Simply Wall St

Wed, 09 Sep 2020
Do Analysts Expect Liquidia Technologies Inc (LQDA) Stock to Rise? - InvestorsObserver

Sat, 29 Aug 2020
Liquidia Technologies, Inc. (LQDA) Seems To Be Turning Some Investors Off - Invest Million

Fri, 28 Aug 2020
Liquidia Announces Notice of Allowance for U.S. Patent Application Covering Methods of Treating Pulmonary Hypertension with Dry Powder Treprostinil - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38
Shares Float (M) 23
% Held by Insiders 26.25
% Held by Institutions 47.03
Shares Short (K) 1,960
Shares Short P. Month (K) 1,990

Stock Financials

EPS -2.360
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.310
Profit Margin
Operating Margin
Return on Assets (ttm) -69.4
Return on Equity (ttm) -276.5
Qtrly Rev. Growth
Gross Profit (p.s.) 0.192
Sales Per Share
EBITDA (p.s.) -1.400
Qtrly Earnings Growth
Operating Cash Flow (M) -54
Levered Free Cash Flow (M) -33

Stock Valuations

PE Ratio -2.46
PEG Ratio
Price to Book value 18.74
Price to Sales
Price to Cash Flow -4.09

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.